BioNTech SE (BNTX) is a Buy on Lung Cancer Treatment Prospects: Clear Street

BioNTech SE (NASDAQ:BNTX) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, Clear Street analysts reiterated a Buy rating on BioNTech SE (NASDAQ:BNTX), buoyed by top-line results on one of the company’s experimental treatments. BioNTech SE (BNTX) is a Buy on Lung Cancer Treatment Prospects: Clear Street Source:unsplash Gotistobart is the company’s anti-CTLA4 therapy in second-line or later squamous non-small cell lung cancer (NSCLC), showing tremendous potential. ...